Advance in susceptibility genes and epigenetic regulation in Hirschsprung's disease

doi:10.16352/j.issn.1001-6325.2023.04.0700

Abstract

Abstract: Hirschsprung's disease(HSCR)is a disease resulted from abnormal enteric nervous system development. The abnormal coding of related genes may affect the migration, proliferation, differentiation or survival of neural crest cells in digestive tract and then result in distal intestinal aganglionosis. The regulation of neural crest cells and surrounding environment involves various genes, signal pathways, transcription factors and epigenetic mechanisms. Therefore, the mutation of related genes and the change of gene expression during the development of intestinal nervous system may be related to the pathogenesis of Hirschsprung's disease. This article reviews the relevant mechanisms involved in the development of enteric nervous system, and summarizes the main genes and epigenetic patterns related to Hirschsprung's disease, such as RET, EDNRB and DNA methylation, which can affect the development of neural crest disease. The review also summarizes the main pathogenesis of Hirschsprung's disease, providing a theoretical basis for the study of Hirschsprung's disease and recommends a new strategy for the prevention and treatment of Hirschsprung's disease.

Key words: Hirschsprung's disease, enteric nervous system, epigenetics

CLC Number:

R333

WANG Taiyao, ZHENG Lifei. Advance in susceptibility genes and epigenetic regulation in Hirschsprung's disease[J]. Basic & Clinical Medicine, 2023, 43(4): 700-705.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.04.0700

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I4/700

References

[1]Nagy N, Guyer RA, Hotta R, et al. RET overactivation leads to concurrent Hirschsprung disease and intestinal ganglioneuromas[J]. Development, 2020, 147: dev190900. doi:10.1242/dev.190900.
[2]Young HM, Hearn CJ, Farlie PG, et al. GDNF is a chemoattractant for enteric neural cells[J].Dev Biol, 2001, 229: 503-516.
[3]Widowati T, Melhem S, Patria SY, et al. RET and EDNRB mutation screening in patients with Hirschsprung disease: functional studies and its implications for genetic counseling[J]. Eur J Hum Genet, 2016, 24: 823-829.
[4]Butler Tjaden NE, Trainor PA. The developmental etio-logy and pathogenesis of Hirschsprung disease[J]. Transl Res, 2013, 162: 1-15.
[5]Okamoto M, Uesaka T, Ito K, et al. Increased RET activity coupled with a reduction in the RET gene dosage causes intestinal aganglionosis in mice[J]. eNeuro, 2021, 8: ENEURO. doi: 10.1523/ENEURO.0534-20.2021.
[6]Garcia-Barcelo MM, Tang CS, Ngan ES, et al. Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease[J].Proc Natl Acad Sci U S A, 2009, 106: 2694-2699.
[7]Fu M, Barlow-Anacker AJ, Kuruvilla KP, et al. 37/67-laminin receptor facilitates neural crest cell migration during enteric nervous system development[J]. FASEB, 2020, 34: 10931-10947.
[8]Lake JI, Heuckeroth RO. Enteric nervous system development: migration, differentiation, and disease[J].Am J Physiol Gastrointest Liver Physiol, 2013, 305: G1-G24. doi: 10.1152/ajpgi.00452.2012.
[9]Jiang Q, Arnold S, Heanue T, et al. Functional loss of semaphorin 3C and/or semaphorin 3D and their epistatic interaction with ret are critical to Hirschsprung disease liability[J]. Am J Hum Genet, 2015, 96: 581-596.
[10]Gonzales J, Le Berre-Scoul C, Dariel A, et al. Sema-phorin 3A controls enteric neuron connectivity and is inversely associated with synapsin 1 expression in Hirschsprung disease[J]. Sci Rep, 2020, 10: 15119. doi: 10.1038/s41598-020-71865-3.
[11]Jiang M, Li C, Cao G, et al. Effects of NRG1 Polymorphisms on Hirschsprung's Disease Susceptibility: A Meta-analysis[J]. Sci Rep, 2017, 7: 9913. doi:10.1038/s41598-017-10477-w.
[12]赵炜疆. 神经调节因子Neuregulin-1 (Nrg1)调节U87-MG细胞的黏附分子L1表达及促迁移作用[J]. 基础医学与临床, 2013, 33: 829-833.
[13]Le TL, Galmiche L, Levy J, et al. Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans[J]. J Clin Invest, 2021, 131: e145837. doi: 10.1172/JCI145837.
[14]Kuhlbrodt K, Herbarth B, Sock E, et al. Sox10, a novel transcriptional modulator in glial cells[J].J Neurosci, 1998, 18: 237-250.
[15]Sham MH, Lui VC, Fu M, et al. SOX10 is abnormally expressed in aganglionic bowel of Hirschsprung's disease infants?[J].Gut, 2001, 49: 220-226.
[16]Torroglosa A, Villalba-Benito L, Luzón-Toro Β, et al. Epigenetic mechanisms in Hirschsprung disease[J].Int J Mol Sci, 2019, 20: 3123. doi: 10.3390/ijms20133123.
[17]Torroglosa A, Enguix-Riego MV, Fernández RM, et al. Involvement of DNMT3B in the pathogenesis of Hirschsprung disease and its possible role as a regulator of neurogenesis in the human enteric nervous system[J]. Genet Med, 2014, 16: 703-710.
[18]Hausser J, Zavolan M. Identification and consequences of miRNA-target interactions-beyond repression of gene expression[J]. Nat Rev Genet, 2014, 15: 599-612.
[19]Cao J. The functional role of long non-coding RNAs and epigenetics[J]. Biol Proced Online, 2014, 16: 11. doi: 10.1186/1480-9222-16-11.
[20]Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges[J]. Nature, 2013, 495: 384-388.
[21]Du C, Shen Z, Zang R, et al. Negative feedback circuitry between MIR143HG and RBM24 in Hirschsprung disease[J]. Biochim Biophys Acta, 2016, 1862: 2127-2136.
[22]Gunadi, Budi NYP, Kalim AS, et al. Aberrant expres-sions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease[J]. Orphanet J Rare Dis, 2019, 14: 5. doi: 10.1186/s13023-018-0973-5.
[23]Li Y, Zhou L, Lu C, et al. Long non-coding RNA FAL1 functions as a ceRNA to antagonize the effect of miR-637 on the down-regulation of AKT1 in Hirschsprung's disease[J]. Cell Prolif, 2018, 51: e12489. doi: 10.1111/cpr.12489.
[24]Soret R, Schneider S, Bernas G, et al. Glial cell-derived neurotrophic factor induces enteric neurogenesis and improves colon structure and function in mouse models of Hirschsprung disease[J]. Gastroenterology, 2020, 159: 1824-1838.e17.